460

-1.61%↓

SANES

9.354

-3.09%↓

SAF

295

-3.81%↓

BBVA

17.94

-1.83%↓

BNP

84.75

-3.11%↓

460

-1.61%↓

SANES

9.354

-3.09%↓

SAF

295

-3.81%↓

BBVA

17.94

-1.83%↓

BNP

84.75

-3.11%↓

460

-1.61%↓

SANES

9.354

-3.09%↓

SAF

295

-3.81%↓

BBVA

17.94

-1.83%↓

BNP

84.75

-3.11%↓

460

-1.61%↓

SANES

9.354

-3.09%↓

SAF

295

-3.81%↓

BBVA

17.94

-1.83%↓

BNP

84.75

-3.11%↓

460

-1.61%↓

SANES

9.354

-3.09%↓

SAF

295

-3.81%↓

BBVA

17.94

-1.83%↓

BNP

84.75

-3.11%↓

Home・Akcijų sąrašas・AB Science SA

AB Science SA

Atidarymo kaina

1.198 1.87

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.172

Max

1.222

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-5.2M
Pardavimai	515K
Pelno marža	-1,005.243
Darbuotojai	36
EBITDA	-2.5M

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-11

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	81M
Ankstesnė atidarymo kaina	-0.67
Ankstesnė uždarymo kaina	1.198

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

1.426 / 1.448 Palaikymas ir pasipriešinimas

AB Science SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-18 22:51; UTC

Uždarbis

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

2026-03-18 21:40; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

2026-03-18 20:31; UTC

Uždarbis

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

2026-03-18 23:49; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

2026-03-18 23:31; UTC

Rinkos pokalbiai

Gold Rises on Likely Technical Recovery -- Market Talk

2026-03-18 22:49; UTC

Rinkos pokalbiai

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

2026-03-18 22:41; UTC

Rinkos pokalbiai

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

2026-03-18 22:36; UTC

Uždarbis

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

2026-03-18 22:24; UTC

Uždarbis

AIA Group Announces New Share Buyback of $1.7B >1299.HK

2026-03-18 22:23; UTC

Uždarbis

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

2026-03-18 22:23; UTC

Uždarbis

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

2026-03-18 21:58; UTC

Uždarbis

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

2026-03-18 21:55; UTC

Rinkos pokalbiai

Uždarbis

Global Equities Roundup: Market Talk

2026-03-18 21:55; UTC

Rinkos pokalbiai

Uždarbis

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

2026-03-18 21:40; UTC

Rinkos pokalbiai

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

2026-03-18 21:16; UTC

Rinkos pokalbiai

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

2026-03-18 21:00; UTC

Svarbiausios naujienos

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

2026-03-18 20:58; UTC

Uždarbis

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

2026-03-18 20:41; UTC

Uždarbis

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

2026-03-18 20:29; UTC

Uždarbis

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

2026-03-18 20:25; UTC

Uždarbis

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

2026-03-18 20:17; UTC

Uždarbis

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

2026-03-18 20:14; UTC

Rinkos pokalbiai

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

2026-03-18 20:09; UTC

Uždarbis

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

2026-03-18 20:07; UTC

Uždarbis

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

2026-03-18 20:06; UTC

Uždarbis

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

2026-03-18 20:04; UTC

Uždarbis

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

2026-03-18 20:04; UTC

Uždarbis

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

2026-03-18 20:04; UTC

Uždarbis

Micron Technology Sees 3Q Gross Margin About 81% >MU

2026-03-18 20:03; UTC

Uždarbis

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Akcijų palyginimas

Kainos pokytis

AB Science SA Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių AB Science SA akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

1.426 / 1.448Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.